HFS
ONC

Hantz Financial Services’s BeOne Medicines Ltd ONC Stock Holding History

Hantz Financial Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Buy
1,231
+208
+20% +$61.3K ﹤0.01% 876
2026
Q1 		$304K Sell
1,023
-220
-18% -$71.2K ﹤0.01% 843
2025
Q4 		$378K Buy
1,243
+204
+20% +$66.8K 0.01% 667
2025
Q3 		$354K Buy
1,039
+780
+301% +$237K 0.01% 617
2025
Q2 		$63K Buy
259
+229
+763% +$56.2K ﹤0.01% 890
2025
Q1 		$8K Buy
+30
New +$7.01K ﹤0.01% 1039

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Hantz Financial Services's ONC Position: Q2 2026 in Review

Hantz Financial Services increased its BeOne Medicines Ltd (ONC) stake by 20% in Q2 2026, buying an estimated $61.3K and bringing the position to 1,231 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Hantz Financial Services first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. The position peaked at $378K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Hantz Financial Services held 1,231 shares of BeOne Medicines Ltd worth $351K as of Q2 2026.
  • Hantz Financial Services bought 208 BeOne Medicines Ltd shares in Q2 2026, an estimated $61.3K.
  • BeOne Medicines Ltd made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #876 holding.
  • Hantz Financial Services first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
  • Hantz Financial Services's BeOne Medicines Ltd position peaked at $378K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.